4-Methylmorpholine → tert-Butyl 4-{4-[5-({[(5-chloro-2-thienyl)carbonyl]amino}methyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}-3,5-dioxo-1-piperazinecarboxylate

HRID 1091421Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1091421
[C:1](C(NCC(O)=O)C(O)=O)([O:3][C:4]([CH3:7])([CH3:6])[CH3:5])=[O:2].C1C=CC2N(O)N=[N:23][C:21]=2[CH:22]=1.CN1CC[O:31][CH2:30][CH2:29]1.CN(C([O:41]N1N=NC2C=CC=CC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.[NH2:58][C:59]1[CH:64]=[CH:63][C:62]([N:65]2[CH2:69][CH:68]([CH2:70][NH:71][C:72]([C:74]3[S:75][C:76]([Cl:79])=[CH:77][CH:78]=3)=[O:73])[O:67][C:66]2=[O:80])=[CH:61][CH:60]=1>ClCCl.CN(C=O)C>[Cl:79][C:76]1[S:75][C:74]([C:72]([NH:71][CH2:70][CH:68]2[O:67][C:66](=[O:80])[N:65]([C:62]3[CH:63]=[CH:64][C:59]([N:58]4[C:22](=[O:41])[CH2:21][N:23]([C:1]([O:3][C:4]([CH3:7])([CH3:6])[CH3:5])=[O:2])[CH2:29][C:30]4=[O:31])=[CH:60][CH:61]=3)[CH2:69]2)=[O:73])=[CH:78][CH:77]=1

Komponenten

8

Versuchsvorschrift

A solution of 199 mg (0.85 mmol) of Boc-iminodiacetic acid, 300 mg (2.2 mmol) of HOBT, 0.66 ml (6 mmol) of N-methylmorpholine and 647 mg (1.7 mmol) of HBTU is admixed with 300 mg (0.85 mmol) of N-{[3-(4-aminophenyl)-2-oxo-1,3-oxazolidin-5-yl}-methyl]-5-chloro-2-thiophene-carboxamide in 6 ml of a mixture of DMF and dichloromethane (1:1). The mixture is stirred overnight, diluted with dichloromethane and then washed with water, saturated ammonium chloride solution, saturated sodium bicarbonate solution, water and saturated sodium chloride solution. The organic phase is dried over magnesium sulphate and concentrated. The crude product is purified by silica gel chromatography (dichloromethane/methanol 98:2). Yield: 134 mg (29% of theory);

Aufarbeitung

  1. washwashed with water, saturated ammonium chloride solution, saturated sodium bicarbonate solution, water and saturated sodium chloride solution
  2. dry with materialThe organic phase is dried over magnesium sulphate
  3. concentrationconcentrated
  4. customThe crude product is purified by silica gel chromatography (dichloromethane/methanol 98:2)

Quellen und Nachweise

ORD-Eintrag
ord-28979aaf9c2d42f4a13a0d3170a4ebbb
Quelldatensatz
uspto-grants-2012_03
Patentnummer
US08129378B2

Notizen zur Reaktion

Wird geladen…